DOCK2 and B-cell chronic lymphocytic leukemia: Therefore, the two signaling pathways are inhibited by separate inhibitors without interference, and there are different upstream regulators that together mediate DOCK2 activation and play a role in the development of CLL (Hasan et al., 2021) (Figure 1).